Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...
Down in the dumps? Help might be hiding in your fridge. A new, first-of-its-kind study suggests a controversial diet could ease severe, drug-resistant depression — with improvements showing up in as ...
Advanced gastroesophageal adenocarcinoma (GEA) with HER2 positivity has long presented significant treatment challenges, with ...
Onvansertib combined with FOLFIRI and Avastin shows dose-dependent improvements in tumor response and disease control for RAS-mutated mCRC. Cardiff Oncology plans a registrational trial to compare ...
Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...
In combined analysis (n = 39), the average wound closure rate was 98%, and all 19 patients previously diagnosed for potential ...
Editor’s Note: The publisher of the study referenced in this story has flagged the report with “expressions of concern.” This story may be updated when the journal posts further information. Women who ...
Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results